Anaphylaxis Treatment Market Report 2026

Anaphylaxis Treatment Market Overview

• Anaphylaxis Treatment market size has reached to $6.59 billion in 2025 • Expected to grow to $9.33 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Surging Prevalence Of Food Allergies Sparks Accelerated Growth In The Anaphylaxis Treatment Market • Market Trend: Innovative Products For Enhanced Emergency Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anaphylaxis Treatment Market?

Anaphylaxis treatment refers to the treatment of life-threatening allergic reactions to foods, insect stings, medications, and latex in which immediate administration of epinephrine is given to reverse the allergic reaction and stabilize the patient’s condition. Rapid medical treatment and comprehensive supportive care are required to effectively manage potentially life-threatening symptoms of anaphylaxis. The main anaphylaxis treatments are epinephrine, antihistamines, steroids, beta-antagonists, and others. Epinephrine refers to a synthetic or extracted version of adrenaline, a chemical utilized commercially, which is the first and most crucial therapy for anaphylaxis, and it must be given as soon as the condition is identified to stop the onset of life-threatening symptoms. These are available in the form of tablets, capsules, and others, which are distributed through hospital pharmacy, retail pharmacy, and online pharmacies for food allergies, pollen allergies, dust mites allergies, and others.

What Is The Anaphylaxis Treatment Market Growth Forecast?

The anaphylaxis treatment market size is expected to see strong growth in the next few years. It will grow to $9.33 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing investments in advanced drug delivery systems, rising focus on patient-centric treatment solutions, expansion of digital pharmacy platforms, growing demand for fast-acting medications, increasing global allergy prevalence. Major trends in the forecast period include increasing use of auto-injectable epinephrine products, rising adoption of multi-drug treatment protocols, growing emphasis on rapid intervention, expansion of retail and online distribution channels, enhanced focus on treatment accessibility.

What Is The Driver Of The Anaphylaxis Treatment Market?

The rise in the prevalence of food allergies is expected to propel the growth of the anaphylaxis treatment market going forward. Food allergies are immune-mediated adverse reactions that occur when the body mistakenly identifies specific food proteins as harmful, triggering responses that can range from mild symptoms to life-threatening anaphylaxis. A key factor driving the rise in the prevalence of food allergies is increasing environmental and dietary exposures during early childhood, which can alter immune system development and heighten sensitivity to common food allergens. Anaphylaxis treatment supports this growing clinical need by providing rapid, life-saving intervention that mitigates severe allergic reactions and enhances patient safety in the context of rising food allergy incidence. For instance, in May 2024, according to the Food Standards Agency, a UK-based government department, around 6% of UK adults equivalent to approximately 2.4 million people were estimated to have a clinically confirmed food allergy in 2024. Therefore, the rise in the prevalence of food allergies is driving the growth of the anaphylaxis treatment industry.

Key Players In The Global Anaphylaxis Treatment Market

Major companies operating in the anaphylaxis treatment market are Merck & Co. Inc., Novartis International AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abelló A/S, Amphastar Pharmaceuticals Inc., Par Pharmaceutical Inc., Pfizer Inc., Sanofi S.A., Bristol Myers Squibb, AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim, Eli Lilly and Company, Takeda Pharmaceutical Company Limited

Global Anaphylaxis Treatment Market Trends and Insights

Major companies operating in the anaphylaxis treatment market are focusing on developing innovative solutions, such as epinephrine injections, to improve emergency response and patient outcomes. An epinephrine injection is a life-saving medication used in severe allergic reactions, capable of rapidly reversing symptoms such as airway constriction, low blood pressure, and hives. For instance, in March 2023, American Regent Inc., a US-based pharmaceutical company, launched sulfite-free epinephrine injection USP. The product is designed for subcutaneous, intramuscular, and intravenous usage; it contains no sulfite or preservatives. Epinephrine is also recommended for adult patients with hypotension linked to septic shock in order to raise mean arterial blood pressure.

What Are Latest Mergers And Acquisitions In The Anaphylaxis Treatment Market?

In October 2023, Amgen Inc. a US-based biopharmaceutical company acquired Horizon Therapeutics Plc for $27.8 billion. With this acquisition, Amgen has a strong chance to diversify its product line and deliver patients treatments for severe inflammatory, autoimmune, and uncommon disorders. Through this acquisition, Amgen is committed to utilizing biology to treat patients with life-threatening disorders. Horizon Therapeutics Plc is an Ireland-based biopharmaceutical company.

What Defines the Anaphylaxis Treatment Market?

The anaphylaxis treatment market consists of sales of bronchodilators, corticosteroids, and vasopressors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anaphylaxis Treatment Market Report 2026?

The anaphylaxis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anaphylaxis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.